About me
Margaret Ruesch is the Vice President of Analytical Research & Development, Biotherapeutics Pharmaceutical Sciences organization. Analytical R&D is responsible for developing in-depth product and process understanding, testing clinical trial materials, authoring investigational and registrational filings, and transferring robust analytical controls for commercial manufacturing to global supply. Analytical R&D supports all biotherapeutic and vaccine candidates within Pfizer, and Margaret has been involved with the successful global approvals of many biotherapeutics and vaccines. Margaret holds a BS in biology from The University of Notre Dame and a PhD in cancer biology from Northwestern University.
